Healthcare of Ontario Pension Plan Trust Fund Takes $27.75 Million Position in Lumexa Imaging Holdings, Inc. $LMRI

Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,500,000 shares of the company’s stock, valued at approximately $27,750,000. Healthcare of Ontario Pension Plan Trust Fund owned approximately 1.59% of Lumexa Imaging as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Assetmark Inc. purchased a new position in Lumexa Imaging during the fourth quarter worth about $36,000. Barclays PLC purchased a new position in Lumexa Imaging during the fourth quarter worth about $133,000. Hudson Bay Capital Management LP purchased a new position in Lumexa Imaging during the fourth quarter worth about $237,000. TD Asset Management Inc purchased a new position in Lumexa Imaging during the fourth quarter worth about $1,264,000. Finally, Geode Capital Management LLC purchased a new position in Lumexa Imaging during the fourth quarter worth about $1,548,000.

Lumexa Imaging Stock Down 2.6%

Shares of NASDAQ:LMRI opened at $9.39 on Tuesday. Lumexa Imaging Holdings, Inc. has a 12 month low of $6.45 and a 12 month high of $19.45. The stock’s 50-day moving average price is $8.85.

Insider Activity

In related news, Director Brett Brodnax bought 35,000 shares of the stock in a transaction dated Tuesday, May 19th. The stock was acquired at an average price of $7.25 per share, for a total transaction of $253,750.00. Following the completion of the purchase, the director owned 62,027 shares in the company, valued at $449,695.75. This represents a 129.50% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

LMRI has been the topic of several recent analyst reports. Barclays reduced their target price on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 20th. Weiss Ratings upgraded Lumexa Imaging from a “sell (e-)” rating to a “sell (e)” rating in a research report on Monday, June 1st. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $16.00.

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).